glp-1 combination therapy The of glucagon-like peptide-1 receptor agonists and sodium–glucose cotransporter-2 inhibitors: a narrative review of existing meta-analysis | Acta Diabetologica TrimRX | GLP-1 vs GIP:

Xianghua Yans lab)

Radiofrequency Treatments : By delivering controlled energy to the skin, radiofrequency can help tighten and rejuvenate the affected areas

Epitalon is not FDA-approved and is classified as a research peptide

Important Notice These products are: Not approved for human consumption Not approved for diagnostic or therapeutic use Not intended for medical application Intended strictly for controlled laboratory research Researchers should use laboratory materials only within lawful research environments

$199/mo injection Compounded semaglutide (injection) $199 first dose, then $299 Compounded semaglutide (oral lozenges) $199 first dose, then $299 Compounded semaglutide (oral drops) $299 first dose, then $326 Compounded semaglutide (oral liposomal tablets) $299 (all doses) Compounded semaglutide (microdose) $149 (all doses) Compounded tirzepatide (injection) $299 first dose, then $399 Compounded tirzepatide (microdose) $199 (all doses) Wegovy (pen) From $149 (promotional through April 2026), then $199$349 Zepbound (vials) $299 first dose, $399 second, $499 third dose (regular price $599$1,049 at higher doses) INCLUDES Initial Lab Test Not included Not included, not required Monthly Membership Fee None None for compounded

Available evidence suggests that these agents have similar efficacy, for example: An RCT comparing valproic acid and lacosamide found that the agents were equally efficacious when adequately dosed (e.g., 400 mg IV lacosamide)